Skip to main content
MedPathMedPath Home
Clinical Trials/NCT00855491
NCT00855491
Completed
Not Applicable

Prospective Evaluation of Posterior Capsule Opacification in Myopic Eyes 4 Years After AcrySof Single-Piece IOL Implantation

Iladevi Cataract and IOL Research Center1 site in 1 country100 target enrollmentJuly 2003
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPosterior Capsule Opacification

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Posterior Capsule Opacification
Sponsor
Iladevi Cataract and IOL Research Center
Enrollment
100
Locations
1
Primary Endpoint
the percentage area of PCO with posterior capsule opacity (POCO) software
Status
Completed
Last Updated
17 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The purpose of this study what to evaluate if axial myopia might influence the development of PCO.

Detailed Description

We sought to prospectively compare PCO in eyes with myopia in relation to axial length with PCO in eyes with normal axial length, to decipher the role of axial myopia in PCO 4 years after surgery for senile cataract.

Registry
clinicaltrials.gov
Start Date
July 2003
End Date
November 2008
Last Updated
17 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Iladevi Cataract and IOL Research Center

Eligibility Criteria

Inclusion Criteria

  • •local residency and presence of a cataract in an otherwise normal eye.
  • •Patients older than 50 years
  • •a dilated pupil after mydriasis
  • •Patients with retinochoroidal atrophy, retinal laser prophylaxis,
  • •hypertension

Exclusion Criteria

  • •nondilating pupil after maximal dilation;
  • •pseudoexfoliation; mature, traumatic, black, or complicated cataracts;
  • •previous intraocular surgery;
  • •previous surgery for glaucoma;
  • •diabetes mellitus
  • •Patients who did not give consent preoperatively

Outcomes

Primary Outcomes

the percentage area of PCO with posterior capsule opacity (POCO) software

Time Frame: 4 years

Secondary Outcomes

  • the presence of PCO within the central 3-mm zone were noted(4 years)

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Evaluation of Posterior Capsule Opacification in Eyes With Diabetes MellitusDevelopment of Posterior Capsule Opacification
NCT01480934Iladevi Cataract and IOL Research Center150
Completed
Not Applicable
Corneal Power, Astigmatism, and Aberration Changes After LASIKMeasurements of Patients Using OCT Before and After LASIK
NCT01893671Oregon Health and Science University22
Completed
Not Applicable
The Influences Of Anterior Capsule Polishing On Anterior Capsular Changes and Intraocular Lenses Stability of Super High Myopic EyesMyopia, High, With Cataract and Anterior Capsule Polished
NCT03142269yin ying zhao20
Unknown
Not Applicable
Posterior Capsular Opacification and Glistenings in Hydrophobic and Hydrophilic Intraocular LensesCataractIntraocular Lens Opacification
NCT04122664Guy's and St Thomas' NHS Foundation Trust176
Active, not recruiting
Not Applicable
PROSPECTIVE STUDY OF OPHTHALMOLOGIC FUNCTION IN PATIENTS RECEIVING LINEZOLID FOR TWO MONTHS OR GREATER - N/A
EUCTR2006-002303-14-SEPfizer Inc. 235 East 42nd Street, New York, NY10017, USA60